CP-105696 = 98 HPLC: A Potent LTB4R Antagonist for Inflammation Research

REF #: 3199648
Short description

CP-105,696 = 98 HPLC 158081-99-3

  • CP-105,696 (1-[(3S,4R)-3-([1,1′-Biphenyl]-4-ylmethyl)-3,4-dihydro-4-hydroxy-2H-1-benzopyran-7-yl]-cyclopentanecarboxylic acid)
  • 98% HPLC
  • CP-105,696 is an orally active, potent and selective leukotriene B4 receptor (LTB4R) antagonist
Quantity :
  • Procurenet Team Tshim Sha Tsui
    Hong Kong Hong Kong 3 years
Delivery options
  • 7 Days Return Back Policy
  • 2 Days Cancellation Policy
  • Ship Only

The CP-105,696 = 98 HPLC 158081-99-3 is an exceptional compound with various applications across diverse research fields. With its high purity of 98%, determined by high-performance liquid chromatography (HPLC), this compound offers unique properties that make it a valuable addition to any laboratory. This detailed product description will highlight its key features and applications.

Key Features:

  • Orally Active: CP-105,696 is designed for easy administration through oral routes, allowing for convenient research and experimentation.
  • Potent and Selective LTB4R Antagonist: As a specific leukotriene B4 receptor (LTB4R) antagonist, CP-105,696 effectively modulates the effects of LTB4, a lipid mediator involved in various inflammatory processes.
  • IC50 aPZ0363: With its specific IC50 value against aPZ0363, CP-105,696 demonstrates its potent activity as an LTB4R antagonist.


CP-105,696 has a wide range of applications in different research areas:

  • Inflammation Research: Due to its potent LTB4R antagonist activity, CP-105,696 is an excellent tool for investigating the role of leukotrienes in inflammatory processes. It can be used to study the molecular mechanisms and potential therapeutic targets for various inflammatory diseases.
  • Drug Discovery: The unique structure and properties of CP-105,696 make it a promising compound for drug discovery programs focused on LTB4R-related disorders. Researchers can explore its potential as a starting point for developing novel therapeutic agents.
  • Biomedical Research: CP-105,696 can be employed in various biomedical studies to examine the role of leukotrienes and LTB4R in physiological and pathological processes. Its potency and selectivity as an LTB4R antagonist support detailed investigations in these areas.

Ingredients and Composition:

The main ingredient in CP-105,696 is (1-[(3S,4R)-3-([1,1'-Biphenyl]-4-ylmethyl)-3,4-dihydro-4-hydroxy-2H-1-benzopyran-7-yl]-cyclopentanecarboxylic acid), which constitutes the majority of its composition. The chemical structure of CP-105,696 includes a cyclopentanecarboxylic acid backbone attached to a biphenyl group and a hydroxychroman group. These specific functionalities contribute to its desired pharmacological effects.

Any minor components or impurities present in CP-105,696 are present at trace levels and have no significant impact on the overall purity or properties of the compound. Thorough quality control processes characterize and quantify these impurities, ensuring the highest level of product purity and consistency.

Additional Information:

CP-105,696 is also recognized by alternative names including (+)-1-(3S, 4R)-[3-(4-Phenylbenzyl)-4-hydroxychroman-7-yl]cyclopentane carboxylic acid, 1-[(3S, 4R)-3-([1, 1'-Biphenyl]-4-ylmethyl)-3, 4-dihydro-4-hydroxy-2H-1-benzopyran-7-yl]-cyclopentanecarboxylic acid, CP-105696, and CP105696. Its CAS number is 158081-99-3.

All categories